ArticleBriefings in bioinformatics2025
HGCMLDA: predicting lncRNA-disease associations using hypergraph contrastive learning and multi-scale attentional feature fusion.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Revealing new associations between lncRNAs and diseases through cross attention mechanism and multiple level feature fusion.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Research has consistently indicated that long non-coding RNAs (lncRNAs) significantly influence the development of numerous diseases. Predicting lncRNA-disease associations (LDAs) will contribute to the prevention and treatment of diseases. However, most existing computational models suffer from several challenges: (i) difficulty in capturing complex higher-order relationships among nodes; (ii) limited number of known associations and neglect of consistency of representations across views; (iii) inadequate fusion of multi-view data. In this research, we introduce an innovative end-to-end method named HGCMLDA for LDA prediction. Firstly, HGCMLDA constructs hypergraphs of lncRNAs and diseases based on integrated similarity matrices utilizing Gaussian mixture model and k-nearest neighbor methods and utilizes hypergraph convolutional network to extract high-order representations of lncRNAs and diseases, followed by contrastive learning to capture information interaction between different views that can alleviate the dependence on limited known associations and enhance the node representations in an unsupervised way. Then, HGCMLDA utilizes multi-scale attentional feature fusion, which considers importance weights of different views and aggregates both global and local context to achieve achieve effective and adequate feature fusion. Subsequently, disease features and lncRNA features are also extracted by using variational autoencoder on the association matrix, so that prior knowledge is effectively incorporated for prediction. Finally, the features of these two parts are concatenated, and matrix completion is performed to predict LDA scores. The results of the comparison experiments indicate that HGCMLDA outperforms five state-of-the-art models for LDA prediction. Case studies for specific diseases demonstrate that HGCMLDA can identify novel associations with high accuracy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.